Fuliang Li
- Hepatology top 2%
- Pathology and Forensic Medicine top 10%
- Epidemiology
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Co-authors
- Zhiyong ZhangZhifang ChaiHaiqing XiaoZijie LiLiuxing FengJiaping LiWenzhe FanYuying Huang
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (6 papers)Cancer Mechanisms and Therapy (4 papers)Liver Disease Diagnosis and Treatment (3 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe FASEB Journal
- Partner nations
- ChinaAustriaUnited States
In The Last Decade
Fuliang Li
19 papers receiving 650 citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Hepatology 299
- Pathology and Forensic Medicine 152
- Epidemiology 119
- Pulmonary and Respiratory Medicine 86
- Molecular Biology 82
Countries citing papers authored by Fuliang Li
This map shows the geographic impact of Fuliang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuliang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuliang Li more than expected).
Fields of papers citing papers by Fuliang Li
This network shows the impact of papers produced by Fuliang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuliang Li. The network helps show where Fuliang Li may publish in the future.
Co-authorship network of co-authors of Fuliang Li
This figure shows the co-authorship network connecting the top 25 collaborators of Fuliang Li. A scholar is included among the top collaborators of Fuliang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuliang Li. Fuliang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)breakdown → | 262 |
| 4 | 2 | |
| 5 | 12 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 19 | |
| 9 | 39 | |
| 10 | 2 | |
| 11 | 11 | |
| 12 | 18 | |
| 13 | 29 | |
| 14 | 2 | |
| 15 | 140 | |
| 16 | 61 | |
| 17 | 11 | |
| 18 | 28 | |
| 19 | 12 | |
| 20 | 10 |
About Fuliang Li
Fuliang Li is a scholar working on Hepatology, Ophthalmology and Geochemistry and Petrology, having authored 20 papers that have together received 664 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer Mechanisms and Therapy (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (299 citations), Geochemistry and Petrology (81 citations) and Pathology and Forensic Medicine (152 citations). Fuliang Li has collaborated with scholars based in China, Austria and United States. Frequent co-authors include Zhiyong Zhang, Zhifang Chai, Haiqing Xiao, Zijie Li, Liuxing Feng, Jiaping Li, Wenzhe Fan, Yuying Huang, Yuliang Zhao and Xiao He. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.